Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | STOXX® Europe 600 Health Care |
| Investment focus | Equity, Europe, Health Care |
| Fund size | EUR 760 m |
| Total expense ratio | 0.46% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 18.06% |
| Inception/ Listing Date | 25 April 2001 |
| Distribution policy | Distributing |
| Distribution frequency | At least annually |
| Fund domicile | Germany |
| Fund Provider | iShares |
| Fund Structure | Contractual Fund |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH |
| Investment Advisor | |
| Custodian Bank | State Street Bank International GmbH |
| Revision Company | Deloitte |
| Fiscal Year End | 1 March |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| AstraZeneca PLC | 14.90% |
| Roche Holding AG | 13.96% |
| Novartis AG | 12.99% |
| Novo Nordisk A/S | 8.21% |
| Sanofi | 5.88% |
| EssilorLuxottica SA | 5.82% |
| GSK Plc | 5.01% |
| argenx | 2.88% |
| Lonza Group AG | 2.50% |
| Haleon | 2.29% |
| Switzerland | 32.96% |
| United Kingdom | 23.40% |
| France | 12.95% |
| Germany | 5.62% |
| Other | 25.07% |
| Health Care | 77.98% |
| Consumer Discretionary | 5.82% |
| Consumer Staples | 2.29% |
| Basic Materials | 1.13% |
| Other | 12.78% |
| YTD | +3.87% |
| 1 month | +6.31% |
| 3 months | +8.19% |
| 6 months | +15.61% |
| 1 year | +8.35% |
| 3 years | +23.68% |
| 5 years | +45.27% |
| Since inception (MAX) | +316.30% |
| 2025 | +7.16% |
| 2024 | +3.86% |
| 2023 | +8.11% |
| 2022 | -6.69% |
| Current dividend yield | 1.52% |
| Dividends (last 12 months) | EUR 1.80 |
| Period | Dividend in EUR | Dividend yield in % |
|---|---|---|
| 1 Year | EUR 1.80 | 1.62% |
| 2025 | EUR 1.80 | 1.66% |
| 2024 | EUR 1.57 | 1.49% |
| 2023 | EUR 1.69 | 1.70% |
| 2022 | EUR 1.59 | 1.47% |
| Volatility 1 year | 18.06% |
| Volatility 3 years | 14.76% |
| Volatility 5 years | 14.63% |
| Return per risk 1 year | 0.46 |
| Return per risk 3 years | 0.50 |
| Return per risk 5 years | 0.53 |
| Maximum drawdown 1 year | -21.34% |
| Maximum drawdown 3 years | -26.42% |
| Maximum drawdown 5 years | -26.42% |
| Maximum drawdown since inception | -48.46% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | EXV4 | - - | - - | - |
| Stuttgart Stock Exchange | EUR | EXV4 | - - | - - | - |
| SIX Swiss Exchange | EUR | SXDPEX | SXDPEX SE SXDPNAV | SXDPEX.S RXPXNAV.DE | |
| XETRA | EUR | EXV4 | SXDPEX GY SXDPNAV | SXDPEX.DE RXPXNAV.DE |